Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The cholera outbreak in Yemen: lessons learned and way forward.

Federspiel F, Ali M.

BMC Public Health. 2018 Dec 4;18(1):1338. doi: 10.1186/s12889-018-6227-6. Review.

2.

Crisis-driven cholera resurgence switches focus to oral vaccine.

[No authors listed]

Bull World Health Organ. 2018 Jul 1;96(7):446-447. doi: 10.2471/BLT.18.020718.

3.

Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015.

Lam E, Al-Tamimi W, Russell SP, Butt MO, Blanton C, Musani AS, Date K.

Emerg Infect Dis. 2017 Jan;23(1):38-45. doi: 10.3201/eid2301.160881.

4.

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

Clemens J, Holmgren J.

Curr Top Microbiol Immunol. 2014;379:231-58. doi: 10.1007/82_2013_353. Review.

PMID:
24402712
5.

Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.

Msyamboza KP, M'bang'ombe M, Hausi H, Chijuwa A, Nkukumila V, Kubwalo HW, Desai S, Pezzoli L, Legros D.

Pan Afr Med J. 2016 Apr 20;23:203. doi: 10.11604/pamj.2016.23.203.8346. eCollection 2016.

6.

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V.

Emerg Infect Dis. 2011 Nov;17(11):2105-12. doi: 10.3201/eid1711.110822.

7.

Improving immunization approaches to cholera.

Saha A, Rosewell A, Hayen A, MacIntyre CR, Qadri F.

Expert Rev Vaccines. 2017 Mar;16(3):235-248. doi: 10.1080/14760584.2017.1249470. Epub 2016 Nov 2. Review.

PMID:
27805467
8.

Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.

Sundaram N, Schaetti C, Merten S, Schindler C, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Public Health. 2016 Jan 14;16:36. doi: 10.1186/s12889-016-2710-0.

9.

Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.

Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Ciglenecki I, Luquero FJ, Azman AS, Cabrol JC.

Lancet Infect Dis. 2017 Apr;17(4):e123-e127. doi: 10.1016/S1473-3099(16)30472-8. Epub 2017 Jan 19. Review.

PMID:
28109819
10.

A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.

Schwerdtle P, Onekon CK, Recoche K.

Prehosp Disaster Med. 2018 Feb;33(1):2-6. doi: 10.1017/S1049023X17007166. Epub 2018 Jan 10. Review.

PMID:
29317005
11.

Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.

Heyerdahl LW, Ngwira B, Demolis R, Nyirenda G, Mwesawina M, Rafael F, Cavailler P, Bernard Le Gargasson J, Mengel MA, Gessner BD, Guillermet E.

Vaccine. 2018 Oct 22;36(44):6491-6496. doi: 10.1016/j.vaccine.2017.10.108. Epub 2017 Nov 7.

12.

Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan.

Peprah D, Palmer JJ, Rubin GJ, Abubakar A, Costa A, Martin S, Perea W, Larson HJ.

Vaccine. 2016 Jul 19;34(33):3823-7. doi: 10.1016/j.vaccine.2016.05.038. Epub 2016 Jun 10.

14.

Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, Park JK, Kwon HJ, Favorov M, Hien NT, Clemens JD.

PLoS Negl Trop Dis. 2011 Jan 25;5(1):e1006. doi: 10.1371/journal.pntd.0001006.

15.

Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea.

Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, Grais RF, Verhoustraeten F, Legros D.

PLoS Med. 2013;10(9):e1001512. doi: 10.1371/journal.pmed.1001512. Epub 2013 Sep 10. No abstract available.

16.

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.

Vaccine. 2004 Jun 23;22(19):2444-51. Review.

PMID:
15193408
17.

Cholera vaccine faces major test in Yemen.

Kupferschmidt K.

Science. 2017 Jun 30;356(6345):1316-1317. doi: 10.1126/science.356.6345.1316. No abstract available.

PMID:
28663447
18.

Use of Vibrio cholerae vaccine in an outbreak in Guinea.

Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Diallo AA, Itama C, Page AL, Quilici ML, Mengel MA, Eiros JM, Serafini M, Legros D, Grais RF.

N Engl J Med. 2014 May 29;370(22):2111-20. doi: 10.1056/NEJMoa1312680.

19.

The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.

Finger F, Bertuzzo E, Luquero FJ, Naibei N, Touré B, Allan M, Porten K, Lessler J, Rinaldo A, Azman AS.

PLoS Med. 2018 Feb 27;15(2):e1002509. doi: 10.1371/journal.pmed.1002509. eCollection 2018 Feb.

20.

The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J.

PLoS Med. 2015 Aug 25;12(8):e1001867. doi: 10.1371/journal.pmed.1001867. eCollection 2015 Aug. Erratum in: PLoS Med. 2016 Mar;13(3):e1001989.

Supplemental Content

Support Center